Pack Of: 1
Quantity: 15 N Tablets
Product Type: Dietary Supplement
Packaging Type: Mono-Carton
Food Preference: Veg
FSSAI Lic. No.: 10014064000439
Product Information:
Asthika Tablet is a dietary supplement for healthy and strong bones.
Each film coated tablet contains:
Calcium Citrate Malate: 1000 mg, Omega-3-Fatty Acids (DHA): 60 mg, Boron: 1.5 mg, Cyanocobalamin (A Part of Methylcobalamin Family): 1500 mcg, Folic Acid: 400 mcg, Vitamin K2-7: 45 mcg, Calcitrol: 0.25 mcg, Zinc Sulphate: 7.5 mg
Nutritional Information (Approximate Values) Per Serving:
Energy Value: 0.4 Kcal, Carbohydrate:0.1 g, Fat: 0.000 g, Cholesterol: 0.000 g
Other Ingredients
Starch, Lactose, Talcum & Silicon Dioxide etc.
Key Benefits:
- Used as a dietary supplement.
- For healthy and strong bones.
Usage Direction:
- Consume Asthika Tablet orally, strictly as directed by a registered healthcare professional, following the recommended dose and schedule.
- Before taking the product, carefully read the leaflet or label instructions provided with the product to ensure proper understanding and usage.
Safety & Other Related Information:
- If allergic to any ingredients of Asthika Tablet, let the healthcare professional known straight away.
- The healthcare professional should be well informed when the concomitant consumption of this one with another medicine or supplement.
- Seek precautions during pregnancy and lactation.
- The product is required to be stored out of reach of children.
Storage Conditions:
- Keep in a cool, dark & dry place. Protect from light.
Disclaimer:
Please be advised that any liability for violations of the FSS Act (Food Safety Standard Act 2006) and its applicable Rules and Regulations rests with the sellers, brand owners, vendors, importers, or manufacturers of the food products. Consumers are strongly encouraged to read labels carefully before using or consuming any products, as reliance solely on the information provided on this website is not recommended. For further information, please contact the manufacturer directly.





